Principle of FLAC-PFC coupling calculation. by Qingwen Li (1510687)

Subjects:

Compressive strength of FRP confined CGC. by Qingwen Li (1510687)

Subjects:

14 Elastic modulus of FRP confined CGC. by Qingwen Li (1510687)

Subjects:

FRP sheets wrapped specimen. by Qingwen Li (1510687)

Subjects:

The schematic of the mechanism of action. by Qingwen Li (1510687)

Subjects:

Coal gangue concrete specimens. by Qingwen Li (1510687)

Subjects:

Elastic modulus of FRP confined CGC. by Qingwen Li (1510687)

Subjects:

GFRP confined concrete specimens. by Qingwen Li (1510687)

Subjects:

13 Compressive strength of FRP confined CGC. by Qingwen Li (1510687)

Subjects:

The effect of feeding and starvation on the proliferative competence and cell cycle re-entry dynamics of Vasa2+/Piwi1+ cells. by Eudald Pascual-Carreras (12115380)

The comparison of the Spectral Exponent in hemispherotomy with a reference pediatric sample across wakefulness and NREM Sleep reveal values compatible with deep sleep in the isolat... by Michele Angelo Colombo (22446342)

Subjects:

Group-level narrow- and broad-band spectral changes after hemispherotomy reveal a marked EEG slowing of the isolated cortex, robust across patients. by Michele Angelo Colombo (22446342)

Subjects:

Effects of bevacizumab addition on VEGF-A concentrations <i>in vitro</i>. by Masashi Okawa (8951294)

Subjects:

The characteristics and clinical features of 12 patients. by Masashi Okawa (8951294)

Subjects:

Effect of adding rhVEGF-A (-121 or -165) on the concentrations of VEGF-A121 and VEGF-A165 in plasma samples. by Masashi Okawa (8951294)

Subjects:

Effect of the VEGF-A–bevacizumab complex removal using immunoprecipitation on the concentrations of VEGF-A121, VEGF-A165, and VEGF-A. by Masashi Okawa (8951294)

Subjects:

Equation of the equilibrium dissociation constant of the antigen-antibody reaction. by Masashi Okawa (8951294)

Subjects:

The original data for the figures. by Masashi Okawa (8951294)

Subjects:

Blood concentrations of VEGF-A121, VEGF-A165, and VEGF-A pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

Subjects:

VEGF-A121, VEGF-A165, and VEGF-A contents per unit platelets. by Masashi Okawa (8951294)

Subjects: